Bicycle Therapeutics plc
BCYC · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $880 | $526 | $339 | $439 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $36 | $24 | $21 | $12 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $13 | $11 | $9 | $8 |
| Total Curr. Assets | $929 | $562 | $369 | $459 |
| Property Plant & Equip (Net) | $17 | $28 | $33 | $18 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $1 | $1 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $11 | $5 | $8 | $3 |
| Total NC Assets | $28 | $33 | $41 | $21 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $957 | $595 | $411 | $480 |
| Liabilities | – | – | – | – |
| Payables | $16 | $13 | $6 | $3 |
| Short-Term Debt | $6 | $5 | $3 | $2 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $10 | $25 | $20 | $19 |
| Other Curr. Liab. | $36 | $27 | $23 | $12 |
| Total Curr. Liab. | $67 | $70 | $53 | $36 |
| LT Debt | $4 | $40 | $41 | $42 |
| Deferred Rev, NC | $91 | $110 | $41 | $52 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $1 | $5 | $4 | $3 |
| Total NC Liab. | $97 | $155 | $86 | $97 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $9 | $9 | $14 | $14 |
| Total Liabilities | $164 | $224 | $140 | $134 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $1 | $1 | $0 | $0 |
| Retained Earnings | -$681 | -$512 | -$331 | -$218 |
| AOCI | $0 | -$1 | $0 | -$3 |
| Other Equity | $1,473 | $883 | $601 | $568 |
| Total Equity | $793 | $371 | $271 | $346 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $957 | $595 | $411 | $480 |
| Net Debt | -$870 | -$481 | -$295 | -$394 |